Home
> LiliumX

LiliumX

We discover new bispecific antibodies against cancer

W21 Biotech Therapeutics Drug discovery

Company

Website

https://www.liliumx.com/

Locations

London, England, United Kingdom / London, England, United Kingdom

Team Size

Industries

Healthcare, Therapeutics

About

Bispecific antibodies are the next breakthrough in cancer therapy, but current R&D is limited by a lack of scalable and flexible design platforms. LiliumX overcomes this limitation by using a modular protein platform, rapidly generating and testing thousands of candidate bispecifics using robotic screening and big data analysis to discover bispecific lead assets with entirely new modes of action.

Founders

A list of all active founders

Name	Title	Email	LinkedIn	Twitter
Arne Scheu	Founder	Sign-In An account is required to download data from YCRM. Almost There! YCRM requires a one-time $30 payment to get access. What You Get Unlimited downloads for 30 days 5000+ YC founders' email, LinkedIn, and Twitter Access to the latest YC batches Access to all CRM data enhancements Get Access View Sample Payment Successful Congrats! You now have unlimited access to the YCRM database for 30 days. If you have any questions or run into issues, please don't hesitate to reach out. We are here to help.	https://www.linkedin.com/in/arne-scheu-aa22b812b/	-
Irsyad Khairil	Founder	Sign-In An account is required to download data from YCRM. Almost There! YCRM requires a one-time $30 payment to get access. What You Get Unlimited downloads for 30 days 5000+ YC founders' email, LinkedIn, and Twitter Access to the latest YC batches Access to all CRM data enhancements Get Access View Sample Payment Successful Congrats! You now have unlimited access to the YCRM database for 30 days. If you have any questions or run into issues, please don't hesitate to reach out. We are here to help.	https://www.linkedin.com/in/irsyad-khairil-bb216b9b/	-